ARKG vs VCIT
ARK Genomic Revolution ETF vs Vanguard Intermediate-Term Corporate Bond ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
VCIT—
Vanguard Intermediate-Term Corporate Bond ETF
Intermediate-term investment-grade corporate bonds.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | VCIT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Holdings data unavailable for ARKG.
VCIT top holdings
Holdings data unavailable for VCIT.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About VCIT
VCIT (Vanguard Intermediate-Term Corporate Bond ETF) is Intermediate-term investment-grade corporate bonds.